1-[1-(3-Methoxymethoxy-phenyl)-cyclohexyl]-1,2,3,6-tetrahydro-pyridine | 127973-01-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1-[1-(3-Methoxymethoxy-phenyl)-cyclohexyl]-1,2,3,6-tetrahydro-pyridine
• 英文别名: 1-[1-[3-(methoxymethoxy)phenyl]cyclohexyl]-3,6-dihydro-2H-pyridine
• CAS: 127973-01-7
• 化学式: C₁₉H₂₇NO₂
• 分子量: 301.429
• InChiKey: UHCIWDIMSADLLR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.58
• 拓扑面积：
  21.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  1,2,3,6-四氢吡啶 在 盐酸 、 magnesium 作用下， 反应 14.0h， 生成 1-[1-(3-Methoxymethoxy-phenyl)-cyclohexyl]-1,2,3,6-tetrahydro-pyridine
  参考文献：
  名称：

  Synthesis, phencyclidine-like pharmacology, and antiischemic potential of meta-substituted 1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridines

  摘要：

  A series of 1-[1-arylcyclohexyl]-1,2,3,6-tetrahydropyridines were prepared by the reaction between 1-(1-cyanocyclohexyl)-1,2,3,6-tetrahydropyridine (1) and an appropriately substituted Grignard reagent. The resulting compounds were tested for their phencyclidine binding site affinities. Selected compounds were then tested for their ability to produce ketamine appropriate responding in monkeys and/or to show neuroprotective effects in a baby rat hypoxia/ischemia model. While it was found that binding site affinity correlated well with discriminative stimulus effects, it was found to be a poor indicator of neuroprotective efficacy within this series.

  DOI：

  10.1021/jm00170a027

文献信息

• THURKAUF, ANDREW;DE, COSTA BRIAN;MATTSON, MARIENA V.;FRANCE, CHARLES P.;P+, J. MED. CHEM., 33,(1990) N, C. 2211-2215
  作者：THURKAUF, ANDREW、DE, COSTA BRIAN、MATTSON, MARIENA V.、FRANCE, CHARLES P.、P+

  DOI：——

  日期：——
• Synthesis, phencyclidine-like pharmacology, and antiischemic potential of meta-substituted 1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridines
  作者：Andrew Thurkauf、Brian De Costa、Mariena V. Mattson、Charles P. France、Madelon T. Price、John W. Olney、James H. Woods、A. E. Jacobson、Kenner C. Rice

  DOI：10.1021/jm00170a027

  日期：1990.8

  A series of 1-[1-arylcyclohexyl]-1,2,3,6-tetrahydropyridines were prepared by the reaction between 1-(1-cyanocyclohexyl)-1,2,3,6-tetrahydropyridine (1) and an appropriately substituted Grignard reagent. The resulting compounds were tested for their phencyclidine binding site affinities. Selected compounds were then tested for their ability to produce ketamine appropriate responding in monkeys and/or to show neuroprotective effects in a baby rat hypoxia/ischemia model. While it was found that binding site affinity correlated well with discriminative stimulus effects, it was found to be a poor indicator of neuroprotective efficacy within this series.